Literature DB >> 18627395

Cutaneous pemphigus vulgaris with skin features similar to the classic mucocutaneous type: a case report and review of the literature.

S Shinkuma1, W Nishie, A Shibaki, D Sawamura, K Ito, Y Tsuji-Abe, K Natsuga, P T Chan, M Amagai, H Shimizu.   

Abstract

Pemphigus vulgaris (PV) is a life-threatening autoimmune blistering skin disease that specifically involves oral mucosa. It was recently shown that a very small number of patients with PV show no mucous membrane involvement although they have circulating autoantibodies directed against both desmoglein (Dsg)1 and Dsg3 that are associated with histopathological suprabasal acantholysis. These cases are classed as cutaneous-type PV. We report here a case of cutaneous-type PV that occurred in a 50-year-old man. Clinical examination revealed numerous tense and spreading blisters and erosions over the patient's entire body, similar to the classic mucocutaneous-type PV. Interestingly, none of the previously reported patients with cutaneous PV had shown skin features like those of mucocutaneous PV, whereas the present case clearly demonstrated very typical clinical features similar to those in mucocutaneous PV.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18627395     DOI: 10.1111/j.1365-2230.2008.02871.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  3 in total

1.  Pemphigus vulgaris with tense bullae.

Authors:  Emilie T Nguyen; Shinko K Lin; Jashin J Wu
Journal:  Perm J       Date:  2015

2.  Selective Elevation of Antibodies to Desmoglein 1 during the Transition from Mucocutaneous to Cutaneous Type Pemphigus Vulgaris.

Authors:  Haruna Matsuda-Hirose; Kazushi Ishikawa; Mizuki Goto; Yutaka Hatano; Sakuhei Fujiwara
Journal:  Ann Dermatol       Date:  2013-05-10       Impact factor: 1.444

3.  Case report: Documentation of cutaneous only pemphigus vulgaris without history of mucosal lesions in North America.

Authors:  John Baker; Kristina Seiffert-Sinha; Animesh A Sinha
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.